SCHEMBL5774264

SCHEMBL5774264

N#C/C=C(/Cl)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 2/20 0.43
CYP3A4 P08684 1/20 0.43
ATM Q13315 1/20 0.43
GABRA1 P14867 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRB1 P18505 1/20 0.42
GABRB2 P47870 1/20 0.42
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RECQL P46063 1/20 0.38
ALOX15 P16050 1/20 0.38
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774267 1.00 TSHR (0.43) TSHRL3MBTL1MAPK1CYP3A4ATM
SCHEMBL16425578 0.81 GABRA1 (0.43) MAPK1CYP3A4ATMGABRA1GABRG2
SCHEMBL4617688 0.81 MAPT (0.46) ATMCES2CES1RECQLALDH1A1
SCHEMBL6611275 0.81 CA2 (0.45) TSHRL3MBTL1RECQLALDH1A1CA1
SCHEMBL4617683 0.81 MAPT (0.46) ATMCES2CES1RECQLALDH1A1
SCHEMBL5197078 0.81 CA2 (0.45) TSHRL3MBTL1RECQLALDH1A1CA1
SCHEMBL5197081 0.81 CA2 (0.45) TSHRL3MBTL1RECQLALDH1A1CA1
SCHEMBL4617678 0.81 MAPT (0.46) ATMCES2CES1RECQLALDH1A1
SCHEMBL121277 0.80 PDE4A (0.44) TSHRL3MBTL1MAPK1CES2CES1
SCHEMBL121278 0.80 PDE4A (0.44) TSHRL3MBTL1MAPK1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed